LUCINI, VALERIA
LUCINI, VALERIA
Dipartimento di Oncologia ed Emato-Oncologia
Effects of Levofloxacin, Aztreonam, and Colistin on Enzyme Synthesis by P. aeruginosa Isolated from Cystic Fibrosis Patients
2022 A. Pani, V. Lucini, S. Dugnani, A. Schianchi, F. Scaglione
Erdosteine enhances antibiotic activity against bacteria within biofilm
2022 A. Pani, V. Lucini, S. Dugnani, F. Scaglione
Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria
2020 G.M. Elisi, A. Bedini, L. Scalvini, C. Carmi, S. Bartolucci, V. Lucini, F. Scaglione, M. Mor, S. Rivara, G. Spadoni
Comparative Emergence of Resistance to Clofoctol, Erythromycin, and Amoxicillin against Community-Acquired Bacterial Respiratory Tract Pathogens in Italy
2019 F. Scaglione, V. Lucini, S. Dugnani, A. Pani
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit
2018 G. Spadoni, A. Bedini, L. Furiassi, M. Mari, M. Mor, L. Scalvini, A. Lodola, A. Ghidini, V. Lucini, S. Dugnani, F. Scaglione, D. Piomelli, K. Jung, C.T. Supuran, L. Lucarini, M. Durante, S. Sgambellone, E. Masini, S. Rivara
Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells
2018 A. Calastretti, G. Gatti, V. Lucini, S. Dugnani, G. Canti, F. Scaglione, A. Bevilacqua
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells
2017 G. Gatti, V. Lucini, S. Dugnani, A. Calastretti, G. Spadoni, A. Bedini, S. Rivara, M. Mor, G. Canti, F. Scaglione, A. Bevilacqua
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines
2015 G. Spadoni, A. Bedini, S. Lucarini, M. Mari, D. Caignard, J.A. Boutin, P. Delagrange, V. Lucini, F. Scaglione, A. Lodola, F. Zanardi, D. Pala, M. Mor, S. Rivara
Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice
2015 L. Ponzoni, M. Moretti, M. Sala, F. Fasoli, V. Mucchietto, V. Lucini, G. Cannazza, G. Gallesi, C.N. Castellana, F. Clementi, M. Zoli, C. Gotti, D. Braida
Antibiotics counteract the worsening of airway remodelling induced by infections in asthma
2014 V. Lucini, R. Ciracì, S. Dugnani, M. Pannacci, F. Pisati, A. Caronno, G. Tirone, F. Scaglione
Synthesis and characterization of new bivalent agents as melatonin- and histamine H3-ligands
2014 D. Pala, L. Scalvini, A. Lodola, M. Mor, L. Flammini, E. Barocelli, V. Lucini, F. Scaglione, S. Bartolucci, A. Bedini, S. Rivara, G. Spadoni
MT1 -selective melatonin receptor ligands: synthesis, pharmacological evaluation, and molecular dynamics investigation of N-{[(3-O-Substituted)anilino]alkyl}amides
2012 S. Rivara, D. Pala, A. Lodola, M. Mor, V. Lucini, S. Dugnani, F. Scaglione, A. Bedini, S. Lucarini, G. Tarzia, G. Spadoni
Comparison of the potency of 10 different brands of Serenoa repens extracts
2012 F. Scaglione, V. Lucini, M. Pannacci, S. Dugnani, C. Leone
In vitro and in vivo pharmacokinetic/pharmacodynamic activity of clofoctol
2012 F. Scaglione, S. Dugnani, V. Lucini, M. Pannacci, L. Paraboni
Toward the definition of stereochemical requirements for MT2-selective antagonists and partial agonists by studying 4-phenyl-2-propionamidotetralin derivatives
2011 A. Bedini, S. Lucarini, G. Spadoni, G. Tarzia, F. Scaglione, S. Dugnani, M. Pannacci, V. Lucini, C. Carmi, D. Pala, S. Rivara, M. Mor
Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide : synthesis, binding affinity and intrinsic activity for MT1 and MT2 melatonin receptors
2011 G. Spadoni, A. Bedini, P. Orlando, S. Lucarini, G. Tarzia, M. Mor, S. Rivara, V. Lucini, M. Pannacci, F. Scaglione
Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors
2010 A. Carocci, A. Catalano, A. Lovece, G. Lentini, A. Duranti, V. Lucini, M. Pannacci, F. Scaglione, C. Franchini
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands
2009 S. Rivara, F. Vacondio, A. Fioni, C. Silva, C. Carmi, M. Mor, V. Lucini, M. Pannacci, A. Caronno, F. Scaglione, G. Gobbi, G. Spadoni, A. Bedini, P. Orlando, S. Lucarini, G. Tarzia
An innovative transdermal drug delivery device for the treatment of type I diabetes
2009 M. Bedoni, M. Casella, E. Donetti, E. Forvi, V. Lucini, C. O’Mahony, F. Scaglione, F. Gramatica
Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia
2009 F. Scaglione, S. Esposito, S. Leone, V. Lucini, M. Pannacci, L. Ma, G.L. Drusano